mebendazole has been researched along with Parkinson Disease in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gatto, M | 1 |
Fernandez Pardal, M | 1 |
Melero, M | 1 |
Zurru, C | 1 |
Scorticati, C | 1 |
Micheli, F | 1 |
1 other study available for mebendazole and Parkinson Disease
Article | Year |
---|---|
L-dopa malabsorption in a parkinsonian patient with Strongyloides stercoralis duodenitis.
Topics: Aged; Animals; Duodenitis; Humans; Intestinal Diseases, Parasitic; Levodopa; Male; Mebendazole; Metr | 1994 |